STCC was set up in November 2019 under the RIE2020 funding as a nationally coordinated, virtual organisation to address the need for a cohesive and collaborative national level cancer Research & Translation platform.
The STCC joint platforms enables collaboration between basic, clinical and translational researchers to explore novel approaches, push promising lines of research and translation, and seed ideas for larger competitive translational grants.
We partner with key stakeholders and institutions to implement joint platforms that are functionally integrated and operational in support of the nation’s long term goals to achieve value-based healthcare and economic outcomes through deeper industry collaborations, patents and invention disclosures, start-ups and clinically validated diagnostics.